We are live on ! Find out more
XGN icon

Exagen
XGN

53 hedge funds and large institutions have $120M invested in Exagen in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.56% more ownership

Funds ownership: 50.88% → 54.45% (+3.6%)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

2% less funds holding

Funds holding: 54 → 53 (-1)

7% less capital invested

Capital invested by funds: $129M → $120M (-$9.32M)

Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
20
Reduced
19
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$8.75M
2
SCM
Stonepine Capital Management
Oregon
+$2.94M
3
SAM
Silvercrest Asset Management
New York
+$2.69M
4
CPA
Cowen Prime Advisors
New York
+$2.43M
5
Morgan Stanley
Morgan Stanley
New York
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$7.92M
2
Nomura Holdings
Nomura Holdings
Japan
-$5.33M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3.55M
4
NCM
Nantahala Capital Management
Connecticut
-$2.08M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
1
Cowen and Company
New York
$18.8M +$8.75M +658,553 +91%
WA
2
Wasatch Advisors
Utah
$14.9M -$7.92M -595,420 -35%
RI
3
RTW Investments
New York
$11.2M – – –
BlackRock
4
BlackRock
New York
$7.94M -$23.7K -1,782 -0.3%
SAM
5
Silvercrest Asset Management
New York
$6.97M +$2.69M +202,692 +65%
Vanguard Group
6
Vanguard Group
Pennsylvania
$6.94M -$129K -9,668 -2%
Morgan Stanley
7
Morgan Stanley
New York
$6.78M +$1.78M +133,723 +37%
PIM
8
Platinum Investment Management
Australia
$5.44M – – –
SCM
9
Stonepine Capital Management
Oregon
$5.31M +$2.94M +221,095 +130%
SC
10
Samjo Capital
New York
$4.01M +$1.2M +90,000 +44%
Deutsche Bank
11
Deutsche Bank
Germany
$2.98M -$1.15M -86,564 -28%
NCM
12
Nantahala Capital Management
Connecticut
$2.88M -$2.08M -156,320 -42%
PCM
13
Perkins Capital Management
Minnesota
$2.81M +$76.4K +5,750 +3%
CPA
14
Cowen Prime Advisors
New York
$2.49M +$2.43M +182,900 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.18M +$285K +21,444 +15%
MS
16
Maven Securities
Jersey
$2.07M -$152K -11,408 -7%
BCI
17
Brinker Capital Investments
Pennsylvania
$1.8M – – –
UBS Group
18
UBS Group
Switzerland
$1.77M +$9.01K +678 +0.5%
State Street
19
State Street
Massachusetts
$1.73M +$458K +34,449 +37%
N
20
Natixis
France
$1.7M +$1.66M +125,000 New
Northern Trust
21
Northern Trust
Illinois
$1.26M -$64.1K -4,824 -5%
PM
22
Penbrook Management
New York
$1.19M +$1.17M +87,750 New
BCM
23
Bridgeway Capital Management
Texas
$1.18M +$126K +9,500 +12%
Millennium Management
24
Millennium Management
New York
$475K -$546K -41,107 -54%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$451K +$253K +19,035 +134%
1
2 3

XGN Hedge Fund Activity: Q3 2021 in Review

53 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q3 2021, worth a combined $120M — down 7.2% from $129M a quarter earlier.

Fund positioning in XGN was balanced in Q3 2021: 5 funds opened new positions, 5 closed out, 20 added to existing stakes and 19 trimmed.

The largest buyer was Cowen and Company, adding an estimated $8.75M. The largest seller was Wasatch Advisors, cutting an estimated $7.92M.

  • 53 institutional investors held Exagen (XGN) as of Q3 2021, down from 54 in Q2 2021.
  • Funds reported $120M of Exagen stock for Q3 2021, down 7.2% quarter-over-quarter.
  • 5 funds opened new Exagen positions in Q3 2021 and 5 closed out, a net change of 0 holders.
  • The largest Exagen buyer in Q3 2021 was Cowen and Company, an estimated $8.75M added.
  • The largest Exagen seller in Q3 2021 was Wasatch Advisors, an estimated $7.92M sold.

Based on aggregated 13F filings for Q3 2021.